Concourse Financial Group Securities, Inc. Coh Bar, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share
Q2 2022 Aug 09, 2022	BUY	$0.17 - $0.34 $0 - $0
Q1 2022 May 09, 2022	BUY	$0.25 - $0.43 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$0.34 - $1.0 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$0.96 - $1.62 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$1.09 - $1.49 $0 - $0
Q1 2021 May 13, 2021	BUY	$1.26 - $2.02 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$0.9 - $1.54 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$0.87 - $2.08 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$1.08 - $4.0 $0 - $0
Q1 2020 May 13, 2020	BUY	$1.01 - $2.74 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$1.2 - $2.34 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$1.3 - $1.76 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$1.63 - $3.3 $0 - $0
Q1 2019 May 15, 2019	BUY	$2.95 - $4.16 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$2.97 - $4.52 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$4.13 - $6.84 $0 - $0

Others Institutions Holding CWBR

# of Institutions

Shares Held

1.14K

Call Options Held

Put Options Held

Hc Financial Advisors Inc

1.14K
Shares

$613
0.0% of portfolio

View Full List

About CohBar, Inc.

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

More about CWBR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account